Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 3e-05 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 4e-05 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |